**Core Concept**
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) characterized by the accumulation of immature granulocytes called promyelocytes. APL is associated with a specific chromosomal translocation, t(15;17), which leads to the formation of the PML-RARA fusion gene.

**Why the Correct Answer is Right**
The correct answer, M3AML, refers to the French-American-British (FAB) classification of AML, which categorizes APL as a distinct subtype. M3AML is characterized by the presence of numerous promyelocytes in the bone marrow and peripheral blood. The PML-RARA fusion gene plays a crucial role in the pathogenesis of APL, leading to the inhibition of granulocytic differentiation and the subsequent accumulation of promyelocytes.

**Why Each Wrong Option is Incorrect**
**Option A:** M1AML is a subtype of AML characterized by the accumulation of myeloblasts. It is not associated with the PML-RARA fusion gene or the presence of promyelocytes.
**Option B:** M2AML is a subtype of AML characterized by the presence of both myeloblasts and granulocytes. While it shares some clinical features with M3AML, it is not associated with the PML-RARA fusion gene.
**Option D:** M4AML is a subtype of AML characterized by the presence of both myeloblasts and immature granulocytes. However, it is not specifically associated with the PML-RARA fusion gene or the presence of promyelocytes.

**Clinical Pearl / High-Yield Fact**
APL is highly responsive to treatment with all-trans retinoic acid (ATRA) and arsenic trioxide, which can induce complete remission in most patients. APL is also associated with a high risk of disseminated intravascular coagulation (DIC), which can be life-threatening if not promptly recognized and treated.

**✓ Correct Answer: C. M3AML**